You just read:

DiaVacs Announces Licensing Agreement with University of Pittsburgh for Novel Dendritic Cell and Microsphere Delivery Technologies for Treatment of Type 1 Diabetes

News provided by

DiaVacs, Inc.

Apr 29, 2014, 09:00 ET